Cargando…

Biologics, cardiovascular effects and cancer

Rheumatoid arthritis (RA) is associated with increased cardiovascular risk. Treatment with tumor necrosis factor (TNF)-inhibitors leads to about a 50% reduction in the first cardiovascular event. TNF-inhibitors could transiently improve flow-mediated vasodilation and improve carotid intima-media thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damjanov, Nemanja, Nurmohamed, Michael T, Szekanecz, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984692/ https://www.ncbi.nlm.nih.gov/pubmed/24642038 http://dx.doi.org/10.1186/1741-7015-12-48

Ejemplares similares

Are biologics more effective than classical disease-modifying antirheumatic drugs?
por: Nurmohamed, Michael T, et al.
Publicado: (2008)

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
por: Choy, Ernest, et al.
Publicado: (2014)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries
por: Codreanu, Catalin, et al.
Publicado: (2015)

Intra-articular autologous conditioned serum and triamcinolone injections in patients with knee osteoarthritis: a controlled, randomized, double-blind study
por: Damjanov, Nemanja, et al.
Publicado: (2023)

Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review
por: Lau, Chak Sing, et al.
Publicado: (2017)

Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients
por: Pavelka, Karel, et al.
Publicado: (2020)

Is atherosclerosis an autoimmune disease?
por: Matsuura, Eiji, et al.
Publicado: (2014)

Temporal Variation of Cardiovascular Diseases: An Internal Biological Rhythm Disruption May Play a Role?
por: Manfredini, Roberto, et al.
Publicado: (2013)

Opportunities and challenges in rheumatology research in Central Europe
por: Szekanecz, Zoltán, et al.
Publicado: (2017)

Cardiovascular adverse effects of sugammadex
por: Kapoor, Mukul Chandra
Publicado: (2020)

Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren’s syndrome: comparative cross-sectional study
por: Šijan Gobeljić, Mirjana, et al.
Publicado: (2020)

Biological effects of cancer-secreted factors on human mesenchymal stem cells
por: Lam, Paula YP
Publicado: (2013)

The increased cardiovascular risk in rheumatoid arthritis: when does it start?
por: Nurmohamed, Michael T
Publicado: (2010)

Disease activity and damage in patients with primary Sjogren’s syndrome: Prognostic value of salivary gland ultrasonography
por: Milic, Vera, et al.
Publicado: (2019)

Biosimilars: To switch or not to switch – that is the question
por: Szekanecz, Zoltán
Publicado: (2020)

CKD Effects on Platelets: Implications for Cardiovascular Risk
por: Baaten, Constance C.F.M.J., et al.
Publicado: (2022)

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease
por: Moey, Melissa Y.Y., et al.
Publicado: (2023)

Cardiovascular Consequences of Skeletal Muscle Impairments in Breast Cancer
por: H. Zieff, Gabriel, et al.
Publicado: (2020)

Nexus of Cancer and Cardiovascular Disease for Australia’s First Peoples
por: Diaz, Abbey, et al.
Publicado: (2020)

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals
por: Szekanecz, Zoltán, et al.
Publicado: (2023)

The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review
por: Nurmohamed, Michael, et al.
Publicado: (2018)

Considerations for routinely testing for high lipoprotein(a)
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Colorectal cancer and cardiovascular disease: A thrombo-inflammatory link?
por: ten Cate, Hugo
Publicado: (2021)

Gene–environment interactions and vitamin D effects on cardiovascular risk
por: Iaccarino, Guido, et al.
Publicado: (2019)

The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer
por: Franchini, Massimo, et al.
Publicado: (2015)

Software that goes with the flow in systems biology
por: Hucka, Michael, et al.
Publicado: (2010)

Weight cycling in combat sports: revisiting 25 years of scientific evidence
por: Lakicevic, Nemanja, et al.
Publicado: (2021)

Biological and Clinical Relevance of H19 in Colorectal Cancer Patients
por: Schwarzenbach, Heidi
Publicado: (2016)

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
por: Dijkshoorn, Bas, et al.
Publicado: (2022)

Novel Strategies to Combat CMV-Related Cardiovascular Disease
por: Vasilieva, Elena, et al.
Publicado: (2020)

Addressing the Bias in Cardiovascular Care: Missed & Delayed Diagnosis of Cardiovascular Disease in Women
por: Johnson, Heather M., et al.
Publicado: (2021)

Complementing genomics and transcriptomics: Phosphoproteomics illuminates systems biology in prostate cancer
por: Tan, Victor M., et al.
Publicado: (2016)

Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer
por: Ferrer, Gerardo, et al.
Publicado: (2022)

Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
por: Fu, Dongliao, et al.
Publicado: (2022)

Pneumococcal vaccination in autoimmune rheumatic diseases
por: Rákóczi, Éva, et al.
Publicado: (2017)

Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis
por: Błyszczuk, Przemysław, et al.
Publicado: (2020)

Lipid-Lowering Drug Effects Beyond the Cardiovascular System: Relevance for Neuropsychiatric Disorders
por: Lohoff, Falk W
Publicado: (2018)

Chemical Biology is.....
por: Ostler, Elizabeth L
Publicado: (2007)

Cardiovascular risk perception in women: true unawareness or risk miscalculation?
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l7o8mmg28fod4q8dh840lcj451